Induction of CYP3A4 by 1α,25-dyhydroxyvitamin D3 in HepG2 cells

Life Sciences

Volumn 73, Issue 2, 2003, Pages 141-149

  Elizondo, Guillermo ^a   Medina Díaz, Irma M ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

CYP3A4; HepG2 cells; Metabolism; Vitamin D

Indexed keywords

CALCITRIOL; CYTOCHROME P450 3A4; MESSENGER RNA; CYP3A PROTEIN, HUMAN; CYP3A4 PROTEIN, HUMAN; CYTOCHROME P450; DEXAMETHASONE;

ARTICLE; CELL ACTIVITY; CELL METABOLISM; CELL STRAIN CACO 2; CELL STRAIN HEPG2; CELL VIABILITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CELL CULTURE; GENETICS;

CALCITRIOL; CELLS, CULTURED; CYTOCHROME P-450 ENZYME SYSTEM; DEXAMETHASONE; ENZYME INDUCTION; HUMANS; RNA, MESSENGER;

EID: 0038063079     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00262-5     Document Type: Article

References (27)

1. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proceedings of the National Academy Sciences U S A. 85(10):1988;3294-3298.
2. Berger U., Wilson P., McClelland R.A., Colston K., Haussler M.R., Pike J.W., Coombes R.C. Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. Journal of Clinical Endocrinology and Metabolism. 67(3):1988;607-613.
3. Blumberg B., Sabbagh W. Jr., Juguilon H., Bolado J. Jr., van Meter C.M., Ong E.S., Evans R.M. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes and Development. 12(20):1998;3195-3205.
4. Christakos S., Raval-Pandya M., Wernyj R.P., Yang W. Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3. Biochemical Journal. 316(Pt 2):1996;361-371.
5. Drocourt L., Ourlin J.C., Pascussi J.M., Maurel P., Vilarem M.J. Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. Journal of Biological Chemistry. 277(28):2002;25125-25132.
6. El-Sankary W., Plant N.J., Gibson G.G., Moore D.J. Regulation of the CYP3A4 gene by hydrocortisone and xenobiotics: Role of the glucocorticoid and pregnane X receptors. Drug Metabolism and Disposition. 28(5):2000;493-496.
7. Forrester L.M., Neal G.E., Judah D.J., Glancey M.J., Wolf C.R. Evidence for involvement of multiple forms of cytochrome P-450 in aflatoxin B1 metabolism in human liver. Proceedings of the National Academy Sciences U S A. 87(21):1990;8306-8310.
8. Gibson G.G., Plant N.J., Swales K.E., Ayrton A., El-Sankary W. Receptor-dependent transcriptional activation of cytochrome P4503A genes: Induction mechanisms, species differences and interindividual variation in man. Xenobiotica. 32(3):2002;165-206.
9. Guengerich F.P. Cytochrome p-450 3A4: Regulation and role in drug metabolism. Annual Review of Pharmacology and Toxicology. 39:1999;1-17.
10. Hashimoto H., Toide K., Kitamura R., Fujita M., Tagawa S., Itoh S., Kamataki T. Gene structure of cyp3A4, an adult-specific form of cytochrome P450 in human livers, and its transcriptional control. European Journal of Biochemistry. 218(2):1993;585-595.
11. Haussler M.R., Whitfield G.K., Haussler C.A., Hsieh J.C., Thompson P.D., Selznick S.H., Dominguez C.E., Jurutka P.W. The nuclear vitamin D receptor: Biological and molecular regulatory properties revealed. Journal of Bone and Mineral Research. 13(3):1998;325-349.
12. Kliewer S.A., Moore J.T., Wade L., Staudinger J.L., Watson M.A., Jones S.A., McKee D.D., Oliver B.B., Willson T.M., Zetterstrom R.H., Perlmann T., Lehmann J.M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 92(1):1998;73-82.
13. Kocarek T.A., Schuetz E.G., Strom S.C., Fisher R.A., Guzelian P.S. Comparative analysis of cytochrome P4503A induction in primary cultures of rat, rabbit, and human hepatocytes. Drug Metabolism and Disposition. 23:1995;415-421.
14. Kolars J.C., Lown K.S., Schmiedlin-Ren P., Ghosh M., Fang C., Wrighton S.A., Merion R.M., Watkins P.B. Cyp3A gene expression in human gut epithelium. Pharmacogenetics. 4:1994;247-259.
15. Li A.P., Kaminski D.L., Rasmussen A. Substrates of human hepatic cytochrome P450 3A4. Toxicology. 104:1995;1-8.
16. Morel F., Beaune P.H., Ratanasavanh D., Flinois J.P., Yang C.S., Guengerich F.P., Guillouzo A. Expression of cytochrome P-450 enzymes in cultured human hepatocytes. European Journal of Biochemistry. 191:1990;437-444.
17. Nelson D.R., Koymans L., Kamataki T., Stegeman J.J., Feyereisen R., Waxman D.J., Waterman M.R., Gotoh O., Coon M.J., Estabrook R.W., Gunsalus I.C., Nebert D.W. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42.
18. Ross T.K., Darwish H.M., DeLuca H.F. Molecular biology of vitamin D action. Vitamins and Hormones. 49:1994;281-326.
19. Schmiedlin-Ren P., Thummel K.E., Fisher J.M., Paine M.F., Watkins P.B. Induction of CYP3A4 by 1 alpha,25-dihydroxyvitamin D3 is human cell line-specific and is unlikely to involve pregnane X receptor. Drug Metabolism and Disposition. 29:2001;1446-1453.
20. Schmiedlin-Ren P., Thummel K.E., Fisher J.M., Paine M.F., Lown K.S., Watkins P.B. Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. Molecular Pharmacology. 51:1997;741-754.
21. Schuetz E.G., Schuetz J.D., Strom S.C., Thompson M.T., Fisher R.A., Molowa D.T., Li D., Guzelian P.S. Regulation of human liver cytochromes P-450 in family 3A in primary and continuous culture of human hepatocytes. Hepatology. 18:1993;1254-1262.
22. Segura C., Alonso M., Fraga C., Garcia-Caballero T., Dieguez C., Perez-Fernandez R. Vitamin D receptor ontogenesis in rat liver. Histochemistry and Cell Biology. 112:1999;163-167.
23. Shimada T., Yamazaki H., Mimura M., Inui Y., Guengerich F.P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics. 270:1994;414-423.
24. Sumida A., Fukuen S., Yamamoto I., Matsuda H., Naohara M., Azuma J. Quantitative analysis of constitutive and inducible CYPs mRNA expression in the HepG2 cell line using reverse transcription- competitive PCR. Biochemical and Biophysical Research Communications. 267:2000;756-760.
25. Thummel K.E., Brimer C., Yasuda K., Thottassery J., Senn T., Lin Y., Ishizuka H., Kharasch E., Schuetz J., Schuetz E. Transcriptional control of intestinal cytochrome P-450 3A by 1alpha,25-dihydroxy vitamin D3. Molecular Pharmacology. 60:2001;1399-1406.
26. Westlind A., Malmebo S., Johansson I., Otter C., Andersson T.B., Ingelman-Sundbergm M., Oscarson M. Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochemical and Biophysical Research Communication. 281:2001;1349-1355.
27. Yamazaki H., Shimada T. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Archives of Biochemistry and Biophysics. 346:1997;161-169.